US Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals

Watchlist
  • 2.600
  • -0.240-8.45%
Close Jul 17 16:00 ET
  • 2.840
  • +0.240+9.23%
Post 19:39 ET
92.62MMarket Cap-2166P/E (TTM)

About Eupraxia Pharmaceuticals Company

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell and John Salvatore Montalbano on May 12, 2011 and is headquartered in Victoria, Canada.

Company Profile

SymbolEPRX
Company NameEupraxia Pharmaceuticals
Founded2011
CEODr. James A. Helliwell, M.D.
MarketNASDAQ
Employees29
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2067 Cadboro Bay Road,Suite 201
CityVictoria
ProvinceBritish Columbia
CountryCanada
Zip CodeV8R 5G4
Phone1-250-590-3968
Websitehttp://www.eupraxiapharmaceuticals.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. James A. Helliwell, M.D.
  • Chief Executive Officer and Director
  • 517.30K
  • Dr. Mark Kowalski, M.D.,Pd.D
  • Chief Medical Officer
  • 988.79K
  • Dr. Amanda Malone
  • Chief Scientific Officer and Chief Operating Officer
  • 368.72K
  • Paul Brennan
  • Chief Business Officer
  • 343.12K
  • Bruce G. Cousins
  • Chief Financial Officer and President
  • 368.72K
  • Dr. Simon Pione, F.R.C.P.C,M.D.,PhD
  • Chairman of the Board
  • 42.23K
  • Dr. Michael Wilmink, M.D.
  • Independent Director
  • 23.56K
  • Dr. Richard M. Glickman,L.L.D.
  • Independent Director
  • 29.86K
  • Paul L. Geyer, P. Eng.
  • Independent Director
  • 23.56K
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 29.86K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg